Trevi Therapeutics (TRVI) Tops Q4 EPS by 1c
Trevi Therapeutics (NASDAQ: TRVI) reported Q4 EPS of ($0.08), $0.01 better than the analyst estimate of ($0.09).
For earnings history and earnings-related data on Trevi Therapeutics (TRVI) click here.
Trevi Therapeutics (NASDAQ: TRVI) reported Q4 EPS of ($0.08), $0.01 better than the analyst estimate of ($0.09).
For earnings history and earnings-related data on Trevi Therapeutics (TRVI) click here.